Search by Title Article Topic - Any -AdvocacyAnnual Scientific MeetingAwardsBoard Certification ReviewCertificationClinical DocumentClinical TrialsCoronavirusEarly CareerFellowshipFuture LeadersHeart Failure Awareness 365Heart Failure GuidelinesHF Research FoundationHFSA CommitteesHFSA Comprehensive Heart Failure ReviewHFSA Learning CenterIn The NewsIndustryJournal of Cardiac FailureLeadershipMembershipMentorshipNursingPartnersPatient ResourcePatient StoryPodcastsPresident's UpdatesPress ReleaseProfessional DevelopmentProvider EducationResearchSocial MediaStatementSubmissionsWomen in Heart Failure Article Type - Any -HFSA NewsIndustry NewsPatient NewsPractice News Mar 5 2019 | MyoKardia Announces Positive Six-Month Safety and Efficacy Data from PIONEER-OLE Study of Mavacamten for the Treatment of Symptomatic, Obstructive HCM Practice News Industry Read More Feb 26 2019 | BRILINTA’s Phase III THEMIS Trial met Primary Endopoint in Patients with Established Coronary Artery Disease and Type-2 Diabetes Practice News Industry Read More Feb 19 2019 | Boehringer Ingelheim and Eli Lilly and Company Announce Top-line Results for CAROLINA Study Practice News Industry Read More Feb 6 2019 | New Development in Akcea’s hATTR Compass Program Practice News Industry Read More Oct 23 2018 | Abbott's HeartMate 3 Heart Pump Now FDA Approved for Advanced Heart Failure Patients Not Eligible for a Heart Transplant Practice News Industry Read More Pagination First page « First Previous page ‹ Previous … Page 12 Page 13 Page 14 Page 15 Page 16 Page 17 Current page 18 Page 19 Page 20 Next page Next › Last page Last »
Mar 5 2019 | MyoKardia Announces Positive Six-Month Safety and Efficacy Data from PIONEER-OLE Study of Mavacamten for the Treatment of Symptomatic, Obstructive HCM Practice News Industry Read More
Feb 26 2019 | BRILINTA’s Phase III THEMIS Trial met Primary Endopoint in Patients with Established Coronary Artery Disease and Type-2 Diabetes Practice News Industry Read More
Feb 19 2019 | Boehringer Ingelheim and Eli Lilly and Company Announce Top-line Results for CAROLINA Study Practice News Industry Read More
Oct 23 2018 | Abbott's HeartMate 3 Heart Pump Now FDA Approved for Advanced Heart Failure Patients Not Eligible for a Heart Transplant Practice News Industry Read More
